[EN] PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS<br/>[FR] DÉRIVÉS DE PYRIDOPYRIMIDINONE UTILISÉS COMME ANTAGONISTES DE L'AHR
申请人:SENDA BIOSCIENCES INC
公开号:WO2021102288A1
公开(公告)日:2021-05-27
The present disclosure relates to compounds of formula (Ia) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling. These compounds may also be useful in treating cancer when administered in combination with at least one additional therapy.
本公开涉及式(Ia)化合物及其药用可接受的盐,包括该化合物的制剂、制备方法、用于制备该化合物的中间体化合物,以及治疗或预防疾病的方法,特别是癌症或与异常AHR信号传导相关的疾病或病况的方法。这些化合物在与至少一种额外疗法联合使用时,也可能有助于治疗癌症。